Following low incidence of respiratory syncytial virus (RSV) infections in 2020 during the COVID-19 pandemic, we noted a resurgence in hospitalised children in spring/summer 2021 following relaxation of public health measures. We compared this outbreak to previous autumn/winter seasons. We found higher weekly case numbers and incidence rates, more cases from urban neighbourhoods with lower socioeconomic status, and similar clinical presentation and severity. Public health implications include the re-evaluation of palivizumab administration and the need for surge capacity planning.
All Keywords
【저자키워드】 COVID-19, seasonality, physical distancing, respiratory syncytial virus (RSV), summer, palivizumab administration, 【초록키워드】 children, COVID-19 pandemic, severity, Infection, Health, respiratory syncytial virus, RSV, outbreak, incidence, administration, Relaxation, socioeconomic status, incidence rates, public health measures, re-evaluation, resurgence, palivizumab, Public, hospitalised, implication, include, 【제목키워드】 children, Epidemic, physical distancing measures, Delayed, Ashdod,
【저자키워드】 COVID-19, seasonality, physical distancing, respiratory syncytial virus (RSV), summer, palivizumab administration, 【초록키워드】 children, COVID-19 pandemic, severity, Infection, Health, respiratory syncytial virus, RSV, outbreak, incidence, administration, Relaxation, socioeconomic status, incidence rates, public health measures, re-evaluation, resurgence, palivizumab, Public, hospitalised, implication, include, 【제목키워드】 children, Epidemic, physical distancing measures, Delayed, Ashdod,
COVID-19 전염병 동안 2020년 호흡기 세포융합 바이러스(RSV) 감염의 낮은 발병률에 이어, 우리는 공중 보건 조치의 완화에 따라 2021년 봄/여름에 입원한 어린이의 부활을 확인했습니다. 이번 발병을 이전 가을/겨울 시즌과 비교했습니다. 우리는 더 높은 주간 사례 수와 발병률, 사회 경제적 지위가 낮은 도시 지역에서 더 많은 사례, 유사한 임상 증상 및 중증도를 발견했습니다. 공중 보건에 미치는 영향에는 팔리비주맙 투여의 재평가와 급증 용량 계획의 필요성이 포함됩니다.